Neostigmine is an anticholinesterase agent used to treat myasthenia gravis and postoperative urinary retention. It increases acetylcholine levels, improving muscle contraction. Neostigmine may cause side effects such as nausea and increased salivation. In summary, Neostigmine is essential for neuromuscular function.
Neostigmine inhibits acetylcholinesterase, leading to increased acetylcholine availability at the neuromuscular junction, enhancing muscle contraction.